F-star Therapeutics, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
License revenue
Operating expenses:
Research and development
General and administrative
Impairment on intangible assets
Total operating expenses
Loss from operations
Interest income
Other non-operating (expense)income:
Other income
Interest expense
Change in fair value of warrant liabilities
Change in fair value of contingent value rights
Change in fair value of convertible debt
Loss before income taxes
Total other non-operating (expense) income, net
Net loss before income taxes
Income tax benefit
Net loss
Unrealized gain (loss) on marketable securities
Net loss attributable to common stockholders
Foreign currency translation
Total comprehensive loss
Basic
Diluted
Basic and diluted adjusted net loss per common shares
Weighted-average number of common shares outstanding, basic and diluted

Comments